MicroRNA from Rhodiola for Fibroplasia Treatment
Summary
USPTO published patent application US20260091052A1 filed by Beijing Baishihekang Pharmaceutical Technology covering microRNA derived from Rhodiola root for prevention and treatment of fibroplasia medical signs and syndromes. The application (No. 19319016) was filed September 4, 2025 and published April 2, 2026, listing five inventors including Chengyu Jiang and Jianchao Du. CPC classifications indicate pharmaceutical compositions and nucleic acid technologies.
What changed
The USPTO published a patent application (US20260091052A1) by Beijing Baishihekang Pharmaceutical Technology for a microRNA composition derived from Rhodiola root intended for preventing or treating fibroplasia. The application covers A61K 31/7105 compositions and C12N 15/113 nucleic acid technologies. The fibroplasia indication suggests applications for conditions involving excessive tissue scarring or fibrosis.
This patent publication is informational and does not impose compliance obligations on other entities. Pharmaceutical companies developing RNA-based therapeutics or fibrotic disease treatments should review the claims to assess potential patent overlap with their own research programs. No response or action is required by third parties; the application represents a defensive intellectual property filing by the assignee.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MICRORNA AND USES THEREOF IN PREVENTION AND/OR TREATMENT OF FIBROPLASIA MEDICAL SIGN AND/OR SYNDROME
Application US20260091052A1 Kind: A1 Apr 02, 2026
Assignee
BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD
Inventors
Chengyu JIANG, Jianchao DU, Zhu LIANG, Jiantao XU, Yan ZHAO
Abstract
Provided are microRNA from a Rhodiola root and uses thereof in the prevention and/or the treatment of a fibroplasia medical sign and/or syndrome.
CPC Classifications
A61K 31/7105 C12N 15/102 C12N 15/113 C12N 15/63 C12N 2310/11 C12N 2310/14
Filing Date
2025-09-04
Application No.
19319016
Related changes
Get daily alerts for ChangeBridge: Patent Apps - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Biotech (C12N) publishes new changes.